165 related articles for article (PubMed ID: 3606081)
1. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of ceftriaxone versus cefotaxime: negative effect of serum albumin binding of ceftriaxone.
Nath SK; Foster GA; Mandell LA; Rotstein C
J Antimicrob Chemother; 1994 Jun; 33(6):1239-43. PubMed ID: 7928818
[No Abstract] [Full Text] [Related]
3. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
Jones RN; Barry AL; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
[TBL] [Abstract][Full Text] [Related]
4. [Influence of protein binding on the antibacterial effects of 2 cephalosporins].
Meinardi G; Grasso S; de Carneri I
G Ital Chemioter; 1985; 32(2):343-6. PubMed ID: 3869113
[No Abstract] [Full Text] [Related]
5. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
Neu HC
Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
Oizumi K; Hayashi I; Aonuma S; Konno K
Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
Ravizzola G; Bonfanti C; Savoldi E; Turano A
Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.
Stevens DL; Bergstrom R; Gibbons A
Diagn Microbiol Infect Dis; 1989; 12(1):73-80. PubMed ID: 2653715
[TBL] [Abstract][Full Text] [Related]
10. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
Cormican MG; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
[TBL] [Abstract][Full Text] [Related]
12. Study of the influence of protein binding on serum bactericidal titres and killing rates in volunteers receiving ceftazidime, cefotaxime and ceftriaxone.
Van der Auwera P; Klastersky J
J Hosp Infect; 1990 Apr; 15 Suppl A():23-34. PubMed ID: 1971641
[TBL] [Abstract][Full Text] [Related]
13. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
Bassler M; Blaschke H; Just M; Daschner FD
Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
[TBL] [Abstract][Full Text] [Related]
14. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.
Asmar BI; Prainito M; Dajani AS
Antimicrob Agents Chemother; 1988 Sep; 32(9):1375-8. PubMed ID: 3195999
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
Piédrola G; Galan I; Leyva A; Maroto MC
Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106
[TBL] [Abstract][Full Text] [Related]
18. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.
Nath SK; Foster GA; Mandell LA; Rotstein C
Can J Infect Dis; 1995 Jan; 6(1):21-7. PubMed ID: 22514377
[TBL] [Abstract][Full Text] [Related]
20. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
Jones RN; Barry AL; Packer RR
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
